MENU
+Compare
RDY
Stock ticker: NYSE
AS OF
Oct 17, 04:59 PM (EDT)
Price
$14.44
Change
+$0.22 (+1.55%)
Capitalization
11.91B

RDY Dr. Reddy's Laboratories Ltd Forecast, Technical & Fundamental Analysis

RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RDY with price predictions
Oct 16, 2025

RDY in upward trend: price may jump up because it broke its lower Bollinger Band on September 29, 2025

RDY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 47 cases where RDY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 16, 2025. You may want to consider a long position or call options on RDY as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RDY just turned positive on October 16, 2025. Looking at past instances where RDY's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDY advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 265 cases where RDY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RDY moved out of overbought territory on September 18, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where RDY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

RDY moved below its 50-day moving average on October 14, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RDY crossed bearishly below the 50-day moving average on October 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RDY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.018) is normal, around the industry mean (17.684). P/E Ratio (18.630) is within average values for comparable stocks, (73.162). Projected Growth (PEG Ratio) (3.197) is also within normal values, averaging (2.099). RDY has a moderately low Dividend Yield (0.006) as compared to the industry average of (0.030). P/S Ratio (3.166) is also within normal values, averaging (46.659).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RDY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RDY is expected to report earnings to fall 2.40% to 19 cents per share on October 24

Dr. Reddy's Laboratories Ltd RDY Stock Earnings Reports
Q3'25
Est.
$0.20
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.03
The last earnings report on July 23 showed earnings per share of 20 cents, missing the estimate of 20 cents. With 802.84K shares outstanding, the current market capitalization sits at 11.91B.
A.I.Advisor
published Dividends

RDY paid dividends on August 06, 2025

Dr. Reddy's Laboratories Ltd RDY Stock Dividends
А dividend of $0.09 per share was paid with a record date of August 06, 2025, and an ex-dividend date of July 25, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SBIT31.931.65
+5.45%
ProShares UltraShort Bitcoin ETF
IMTB44.540.16
+0.35%
iShares Core 5-10 Year USD Bond ETF
IBIC25.72-0.01
-0.04%
iShares iBonds Oct 2026 Term Tips ETF
NVBU28.08-0.14
-0.51%
AllianzIM U.S. Equity Buffer15 UncNovETF
PWV63.88-0.80
-1.24%
Invesco Large Cap Value ETF

RDY and Stocks

Correlation & Price change

A.I.dvisor tells us that RDY and COLL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and COLL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+1.07%
COLL - RDY
30%
Poorly correlated
+1.00%
AVDL - RDY
28%
Poorly correlated
-1.06%
VTRS - RDY
27%
Poorly correlated
+1.20%
HROW - RDY
27%
Poorly correlated
-3.85%
TAK - RDY
25%
Poorly correlated
+0.14%
More

Groups containing RDY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+1.07%
Pharmaceuticals: Generic
industry (220 stocks)
30%
Poorly correlated
-0.14%